""

about | Maps & Directions | contact | admissions | faculty | alumni & development | library | Tech Support Center | dean's office | Policies & Procedures

FAculty directory

Back to alphabetical index

Abdullah M. S. Al-Osaimi, MD, FACP, FACG, AGAF

 

 

Abdullah M. S. Al-Osaimi, MD, FACP, FACG, AGAF

 

 

Chief, Division of Hepatology

Medical Director, Liver Transplantation

Associate Professor, Medicine

Telephone:  215-707-5067

Email: Abdullah.Al-Osaimi@tuhs.temple.edu

 

Department of Medicine, Section of Gastroenterology

 

Educational Background:

 

MBBS, King Saud University School of Medicine, Riyadh, Saudi Arabia, 1993

 

Internship, Department of Medicine, Pediatrics, Surgery and Obstetrics & Gynecology, Security Forces Hospital, Riyadh, Saudi Arabia, 1994

 

Residency, Internal Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia, 1999

 

Fellowship, Gastroenterology and Hepatology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia, 2001

 

Fellowship, Liver Transplantation Hepatology, University of Virginia Health System, Charlottesville, VA, 2003

 

Return to top

 

 

certifications:

 

  • Liver Transplant Hepatology
  • Gastroenterology
  • Internal Medicine

 

Return to top

 

 

 

clinical Interests:

 

  • Novel non-invasive techniques for assessing liver fibrosis including fibrocyte levels and magnetic resonance spectroscopy
  • Fatty liver disease
  • Treatment of Hepatitis C in the pre- and post-transplant setting

Return to top

 

 

research interests:

 

  • Exploring and conducting new HCV therapies in the post-liver transplant population
  • Liver transplant outcomes

Return to top

 

 

Professional Affiliations:

 

  • American Transplant Society
  • International Liver Transplant Society
  • American Association for the Study of Liver Diseases
  • International Hepatitis Society
  • American College of Gastroenterology
  • American Gastroenterological Association
  • American College of Physicians
  • American Medical Association

 

Return to top

 

 

PUBMED PUBLICATIONS :


Recent Medically Related Publications, Obtained from PubMed (Click on PubMed ID to view abstract)

24987571. Saad WE, Bleibel W, Adenaw N, Wagner CE, Anderson C, Angle JF, Al-Osaimi AM, Davies MG, Caldwell S, Thrombocytopenia in Patients with Gastric Varices and the Effect of Balloon-occluded Retrograde Transvenous Obliteration on the Platelet Count. J Clin Imaging Sci 4:(24)2014

24798128. Saad WE, Schwaner S, Lippert A, Sabri SS, Al-Osaimi A, Matsumoto AH, Angle JF, Caldwell S, Management of Stomal Varices with Transvenous Obliteration Utilizing Sodium Tetradecyl Sulfate Foam Sclerosis. Cardiovasc Intervent Radiol :()2014 May 6

24373228. Cosgrove ND, Al-Osaimi AM, Sanoff HK, Morris MM, Read PW, Cox DG, Mann JA, Argo CK, Berg CL, Pelletier SJ, Maluf DG, Wang AY, Photodynamic therapy provides local control of cholangiocarcinoma in patients awaiting liver transplantation. Am J Transplant 14:2(466-71)2014 Feb

23939627. Saad WE, Wagner CC, Lippert A, Al-Osaimi A, Davies MG, Matsumoto AH, Angle JF, Caldwell S, Protective value of TIPS against the development of hydrothorax/ascites and upper gastrointestinal bleeding after balloon-occluded retrograde transvenous obliteration (BRTO). Am J Gastroenterol 108:10(1612-9)2013 Oct

23681780. Saad WE, Wagner CC, Al-Osaimi A, Bliebel W, Lippert A, Davies MG, Sabri SS, Turba UC, Matsumoto AH, Angle JF, Caldwell S, The effect of balloon-occluded transvenous obliteration of gastric varices and gastrorenal shunts on the hepatic synthetic function: a comparison between Child-Pugh and model for end-stage liver disease scores. Vasc Endovascular Surg 47:4(281-7)2013 May

23021831. Saad WE, Al-Osaimi AM, Caldwell SH, Pre- and post-balloon-occluded retrograde transvenous obliteration clinical evaluation, management, and imaging: indications, management protocols, and follow-up. Tech Vasc Interv Radiol 15:3(165-202)2012 Sep

23006457. Bleibel W, Al-Osaimi AM, Hepatic encephalopathy. Saudi J Gastroenterol 18:5(301-9)2012 Sep-Oct

22942550. Sauer BG, Sabri SS, Shami VM, Al-Osaimi AM, Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Follow-Up and Postprocedural Imaging. Semin Intervent Radiol 28:3(325-32)2011 Sep

22942546. Al-Osaimi AM, Sabri SS, Caldwell SH, Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Preprocedural Evaluation and Imaging. Semin Intervent Radiol 28:3(288-95)2011 Sep

22942544. Al-Osaimi AM, Caldwell SH, Medical and endoscopic management of gastric varices. Semin Intervent Radiol 28:3(273-82)2011 Sep

22821361. Everson GT, Terrault NA, Lok AS, Rodrigo del R, Brown RS Jr, Saab S, Shiffman ML, Al-Osaimi AM, Kulik LM, Gillespie BW, Everhart JE, A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation. Hepatology 57:5(1752-62)2013 May

22574232. Cupino AC, Hair CD, Angle JF, Caldwell SH, Rich TA, Berg CL, Northup PG, Al-Osaimi AM, Argo CK, Does external beam radiation therapy improve survival following transarterial chemoembolization for unresectable hepatocellular carcinoma? Gastrointest Cancer Res 5:1(13-7)2012 Jan

21777298. Truesdale AE, Caldwell SH, Shah NL, Argo CK, Al-Osaimi AM, Schmitt TM, Northup PG, Sorafenib therapy for hepatocellular carcinoma prior to liver transplant is associated with increased complications after transplant. Transpl Int 24:10(991-8)2011 Oct

21353984. Sabri SS, Swee W, Turba UC, Saad WE, Park AW, Al-Osaimi AM, Caldwell SH, Matsumoto AH, Angle JF, Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam. J Vasc Interv Radiol 22:3(309-16; quiz 316)2011 Mar

20855067. Baltz JG, Argo CK, Al-Osaimi AM, Northup PG, Mortality after percutaneous endoscopic gastrostomy in patients with cirrhosis: a case series. Gastrointest Endosc 72:5(1072-5)2010 Nov

20624660. Caldwell S, Ikura Y, Dias D, Isomoto K, Yabu A, Moskaluk C, Pramoonjago P, Simmons W, Scruggs H, Rosenbaum N, Wilkinson T, Toms P, Argo CK, Al-Osaimi AM, Redick JA, Hepatocellular ballooning in NASH. J Hepatol 53:4(719-23)2010 Oct

20009134. Caldwell SH, Lee VD, Kleiner DE, Al-Osaimi AM, Argo CK, Northup PG, Berg CL, NASH and cryptogenic cirrhosis: a histological analysis. Ann Hepatol 8:4(346-52)2009 Oct-Dec

19642177. McIntosh A, Hagspiel KD, Al-Osaimi AM, Northup P, Caldwell S, Berg C, Angle JF, Argo C, Weiss G, Rich TA, Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma. Cancer 115:21(5117-25)2009 Nov 1

19559425. Procaccini NJ, Al-Osaimi AM, Northup P, Argo C, Caldwell SH, Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis. Gastrointest Endosc 70:5(881-7)2009 Nov

19501928. Argo CK, Northup PG, Al-Osaimi AM, Caldwell SH, Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol 51:2(371-9)2009 Aug

19413580. Schmitt TM, Kumer SC, Al-Osaimi A, Shah N, Argo CK, Berg C, Pruett TL, Northup PG, Combined liver-kidney and liver transplantation in patients with renal failure outcomes in the MELD era. Transpl Int 22:9(876-83)2009 Sep

19318980. Argo CK, Iezzoni JC, Al-Osaimi AM, Caldwell SH, Thiazolidinediones for the treatment in NASH: sustained benefit after drug discontinuation? J Clin Gastroenterol 43:6(565-8)2009 Jul

19274750. Caldwell SH, de Freitas LA, Park SH, Moreno ML, Redick JA, Davis CA, Sisson BJ, Patrie JT, Cotrim H, Argo CK, Al-Osaimi A, Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitis. Hepatology 49:6(1888-95)2009 Jun

19166244. Reardon KA, McIntosh AF, Shilling AT, Hagspiel KD, Al-Osaimi A, Berg C, Caldwell SH, Northup PG, Angle F, Mulder R, Rich TA, Treatment of primary liver tumors with Yttrium-90 microspheres (TheraSphere) in high risk patients: analysis of survival and toxicities. Technol Cancer Res Treat 8:1(71-7)2009 Feb

16944010. Sundaram V, Al-Osaimi AM, Lewis JJ, Lisman T, Caldwell SH, Severe prolongation of the INR in spur cell anemia of cirrhosis: true-true and related? Dig Dis Sci 51:7(1203-5)2006 Jul

16540770. Caldwell SH, Argo CK, Al-Osaimi AM, Therapy of NAFLD: insulin sensitizing agents. J Clin Gastroenterol 40 Suppl 1:(S61-6)2006 Mar

16540769. Chang CY, Argo CK, Al-Osaimi AM, Caldwell SH, Therapy of NAFLD: antioxidants and cytoprotective agents. J Clin Gastroenterol 40 Suppl 1:(S51-60)2006 Mar

15791607. Al-Osaimi AM, Berg CL, Caldwell SH, Intermittent disconjugate gaze: a novel finding in nonalcoholic steatohepatitis and cryptogenic cirrhosis. Hepatology 41:4(943)2005 Apr

15508109. Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM, Obesity and hepatocellular carcinoma. Gastroenterology 127:5 Suppl 1(S97-103)2004 Nov

15139494. Al-Osaimi AM, Berg CL, Association of primary sclerosing cholangitis and celiac disease: a case report and review of the literature. Dig Dis Sci 49:3(438-43)2004 Mar

15122772. Le TH, Caldwell SH, Redick JA, Sheppard BL, Davis CA, Arseneau KO, Iezzoni JC, Hespenheide EE, Al-Osaimi A, Peterson TC, The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis. Hepatology 39:5(1423-9)2004 May

19861804. Al Himali SH, Al Osaimi AM, Dahab ST, Khuroo MS, Al Ashgar HI, Budd Chiari syndrome: experience at King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. Saudi J Gastroenterol 9:1(11-4)2003 Jan

Return to top